Extended Dosing With Eltrombopag for Severe Aplastic Anemia
Clinical trial NCT01891994 · COMPLETED
Trial details
- NCT number
- NCT01891994
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-28
- Primary completion
- 2017-10-16
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.